The survival of HER2‐positive HR‐negative breast cancer patients was significantly affected by Stage, Age, M‐code, T‐code, N‐code, Surg, Marital, Chemotherapy, Liver, Brain, Lung, Radiation, Bone, and Hist in univariate analysis (Table 2). Here, ERBB2 is linked to breast carcinoma.